Saturday, October 22, 2016 7:30:31 AM
[edited to suit TOS (I hope)]
Message to this board from Gene Seymour, taken from an email to me from GS sent Dec 2, 2014, at 02:11 ET.
Note: I’ve removed a possibly problematic word and replaced it with “someone with whom I differ”
Otherwise, Dr. S’s message remains exactly as he wrote it.
Quote:
Had dinner with an investment advisor whose clients hold large positions in NNVC
Against my will, he showed me a recent … post [from someone with whom I differ] that said tox wouldn’t be completed in 2014 (true because it didn’t start until October)
Also, [someone with whom I differ] complained that the NYSE move wasn’t good (nonsense since we now have 65 institutions as investors and we’re on the Russell 2000. In addition, it enabled us to raise $35M giving us a $42M war chest). With the market crashing, we would be going out of business had we not done the uplift and the raise
We’re now well positioned for success
The plant is completed and scale-up continues
A contract with USAMRIID has been signed (What a coup that was)
Ebola will be ready to ship as soon as USAMRIID comes back on line after their annual cleaning of the facility
We created the MERS drug for the British government (remember that disease) in short order and if Ebola hadn’t come along, they would have tested it by now
We’re actively hiring and a group of new scientists are starting this month
All of the TheraCour scientists are under Dr Diwan’s direction so they’re essentially full-time NNVC employees
The lawsuit with Brammel was settled
It’s been a helluva good 14 months
What most people don’t seem to realize is that any other pharma would spend 12-14 years and $2.55B taking a drug to market
We plan to do it in 10 years for $50M
And if they want to do a second drug, they have to start from scratch.
For us, the time for new drug development is measured in weeks, not years
That’s the most amazing thing about the platform technology concept
Gene
Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
eugene@nanoviricides.com
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange
The SwingTrade Portfolio was up 36.2% in 2014, 83.5% in 2013, and 546.6% since inception.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110307454
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM